Corrigendum to "Co-delivery of Poria cocos extract and doxorubicin as an 'all-in-one' nanocarrier to combat breast cancer multidrug resistance during chemotherapy" [Nanomedicine: Nanotechnology, Biology, and Medicine 23 (2020) 102095].